OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Psychiatry is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	859
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	566
Assumptions and Limitations of the Synthetic Control Method	479
Error in Results	323
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	320
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	263
JAMA Psychiatry	245
Managerial and Organizational Challenges in the Age of AI	230
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	221
Integrating Financing Variables Into Behavioral Health Policy Implementation Research	217
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	205
Diagnosing and Treating ADHD in Adults	199
Potential Lessons for DSM From Contemporary Philosophy of Science	183
Overmystifying the Psychedelic Experience	173
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression	169
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	167
JAMA Psychiatry	164
The Reliability of Traumatic and Adverse Experiences	160
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	157
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	154
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	147
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	129
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	125
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	119
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	119

Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans	118
An Opportunity to Advance Cannabis Science—DEA Rescheduling	115
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	114
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	113
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	112
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	110
Errors in Figures 1 and 2	109
JAMA Network Call for Papers on Health and the 2024 US Election	107
JAMA Psychiatry	106
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	104
JAMA Psychiatry	104
Error in Byline	102
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	101
Searching the Brain for the Cause of Psychosis	99
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	97
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	97
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	95
Hyperalgesia in Patients With a History of Opioid Use Disorder	92
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	89
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	88
Addiction Medicine Physicians and Medicinal Cannabinoids	88
Living Alone and Drug Overdose Deaths in the US	87
Perinatal Mental Health Outcomes Following Natural Disasters	86
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	85
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	85
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	84
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	83
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	78
Errors in Figures 3, 4, and 5	78
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	78
JAMA Psychiatry—The Year in Review, 2021	74
Associating Violence With Schizophrenia—Risks and Biases—Reply	74
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	74
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	73
JAMA Psychiatry	73
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands	71
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	71
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	71
Measures of General Intelligence and Risk for Alcohol Use Disorder	70
Expanding Current Approaches to Solve the Opioid Crisis	70
JAMA Psychiatry	69
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	69
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	68
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	68
Physician Suicide and Associated Features—What Defines a Physician?	68
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	64
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	63
Trends in Outpatient Psychotherapy Among Adults in the US	63
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	62
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	61

Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	60
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	60
Social Determinants of Health and Suicide-Related Outcomes	60
Stratified Care vs Stepped Care for Depression	59
Errors in Author Affiliations, Table, and Figure 3	58
Error in Figure 2	58
Errors in Text, Tables, and Figure	57
Reducing the Risks of Nuclear War	57
Suicide Risk—A Specific Intervention Target	57
Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency	56
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity—Reply	56
Written Exposure Therapy Finds Solid Footing Alongside First-Line Psychotherapies for Posttraumatic Stress Disorder	56
Do Not Rule Out Double-blind Placebo Run-in Periods for Randomized Clinical Trials	56
Loss of PTSD Diagnosis in Response to Evidence-Based Treatments	55
GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain	55
The Need for Functional Assessments in School-Based Mental Health Intervention Research	54
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety	54
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression	54
Ultrarare Coding Variants and Cognitive Function in Schizophrenia	54
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder	53
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021	53
Emotional Experience of People With Schizophrenia and People at Risk for Psychosis	52
Brief Cognitive Behavioral Therapy for Suicidal Inpatients	52
All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis	52
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19	52
JAMA Psychiatry	51
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation	50
Cognitive Behavior Therapy for Mental Disorders in Adults	50
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia	50
Rural and Urban Trends in Mental Health Readmissions	50
Adverse Childhood Experiences and Mental Distress Among US Adults by Sexual Orientation	49
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank	48
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US	48
Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care	48
Prospective and Retrospective Measures of Child Maltreatment and Their Association With Psychopathology	48
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk	47
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder	46
Association of Ambient Temperature With the Prevalence of Intimate Partner Violence Among Partnered Women in Low- and Middle-Income South Asian Countries	46
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals	46
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	46
JAMA Psychiatry	45
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	45
Sex Differences in Autism Heritability and Likelihood	45
Errors in Byline and Abstract	44
Errors in Results and Tables	43
Error in Title of Figure 1	43
Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood	42
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes	42
Transdisciplinary Science and Research Training in Psychiatry	42
From Static to Dynamic Prediction of Suicide Risk	42
Precision Assignment to Psychosocial Interventions for Late-Life Depression	42
JAMA Psychiatry—The Year in Review 2024	41
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	41
Toward 90-90-90 Goals for Global Mental Health	41
JAMA Psychiatry	41
Effect of General Practitioner Training in a Collaborative Child Mental Health Care Program on Children’s Mental Health Outcomes in a Low-Resource Setting	40
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	40
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	40
Acupuncture for Combat-Related Posttraumatic Stress Disorder	40
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis	40
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy	40
Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic	39
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy	39
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder	39
VA/Department of Defense Clinical Practice Guideline for PTSD and ASD	39
Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials—Reply	39
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections	39
Physician Suicide and Associated Features—What Defines a Physician?—Reply	39
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk—Reply	38
Combination Antidepressant Therapy vs Monotherapy—Further Considerations—Reply	38
Complex Interaction of Lithium With Kidney and Bone Health	38
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety	37
JAMA Psychiatry	37
JAMA Psychiatry	37
Informant Effect on Placebo Response in Mental Disorders—Reply	36
Mental Health Treatment Gap—The Implementation Problem as a Research Problem	36
Mental Health Care Support in Rural India	36
Error in Figure 1	36
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials	36
Error in Figure	36

Investing in a Research Workforce With Personal Experience of Serious Mental Illness	36
Prescription Stimulant Prescribing, Nonmedical Use, and Shortages	36
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms	35
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis	35
Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia	35
Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act	35
Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder	34
Stimulant Use Disorder Diagnoses in Adolescent and Young Adult Medicaid Enrollees	34
Female Physician Suicide Compared to the General Population	33
Brain Morphometry Normative Modeling—Omit Global Thickness—Reply	32
Issues With Person-Time and Repetitive Event Calculation	32
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	32
Heart Rate Variability Biofeedback for Substance Use Disorder	32
Short-Term Trials Underestimate Antidepressant Withdrawal—Reply	32
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis	32
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of Life	31
Coding Error for the Sex Variable in a Meta-analysis	31
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	31
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	31
Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain	31
COVID-19 and Risk for Mental Disorders Among Adults in Denmark	31
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	31
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	30
Data-Driven Contingency Management Incentive Magnitudes	30
Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment	30
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	30
Cannabis Use Among Individuals With Psychosis After State-Level Commercial Cannabis Legalization	30
Change to Open Access Status	30
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders	30
Issues With Person-Time and Repetitive Event Calculation—Reply	29
International Variation in Clozapine Hematologic Monitoring—A Call for Action	29
Lessons Learned From Drug Decriminalization Remedies in British Columbia	29
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	29
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	29
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	29
Preaddiction—A Missing Concept for Treating Substance Use Disorders	29
Inflammatory Exposure and Depression in Older Adults With Insomnia	28
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	28
Patterns of Brain Maturation in Autism and Their Molecular Associations	28
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	27
Distinct Convergent Brain Alterations in Sleep Disorders and Sleep Deprivation	27
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	27
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	27
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	27
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	26
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	26
JAMA Psychiatry Editorial Fellow	26
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	26
Error in Results and in the Figure 3B Label and Plotted Values	26
Suicidality Calls to a National Helpline After a Terror Attack and War	26
JAMA Psychiatry Peer Reviewers in 2021	26
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	26
JAMA Psychiatry Editorial Fellow	26
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	26
Antipsychotic Medications and Mortality in Children and Young Adults	25
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	25
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	25
Value-Based Payment and Behavioral Health	25
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System	25
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	25
Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025.	25
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	24
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	24
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	24
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	24
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	23
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	23
Error in Figure 2	23
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us—Reply	23
Psychopharmacologic Considerations for Transgender and Gender Diverse People	23
Association Between Physical Activity and Risk of Depression	23
Errors in Network Meta-Analysis of Generalized Anxiety Disorder Psychotherapies	23
Change to Open Access Status	23
Cognitive Function in People With Familial Risk of Depression	23
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	23
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression	23
Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021	22
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy	22
JAMA Psychiatry	22
Parental Mental Disorders and Offspring Mortality up to Middle Age	22
Error in Figure Caption	22
Error in Display of Author Name	22
Preliminary Research Priorities for Factors Influencing Individual Outcomes for Users of the US National Suicide Prevention Lifeline	22
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions	22
Gratitude and Mortality Among Older US Female Nurses	21
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression	21
Sleep Abnormalities in Different Clinical Stages of Psychosis	21
Anorexia Nervosa—Facts, Frustrations, and the Future	21
Climate Events, Displacement, and Mental Health—Uprooted	21
Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials	21
National Data on Age Gradients in Well-being Among US Adults	21
Promoting Social Prescribing in Psychiatry—Using Shared Decision-Making and Peer Support	21
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	21
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases	20
Error in Results	20